AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionSummit Asset Management, LLC
Latest Disclosed Ownership4,910 shares
Latest Disclosed Value $ 1,067,850
Summit Asset Management, LLC reports 0.02% increase in ownership of 4AB / AbbVie Inc.

On May 8, 2026 - Summit Asset Management, LLC filed a 13F-HR form disclosing ownership of 4,910 shares of AbbVie Inc. (BG:4AB) valued at $1,067,850 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 4,909 shares of AbbVie Inc.. This represents a change in shares of 0.02% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F ABBVIE COM 00287Y109 4,910 1 0.02 1,068 -4.82 0.1486
2026-02-09 2025-12-31 13F ABBVIE COM 00287Y109 4,909 51 1.05 1,122 -0.27 0.1587
2025-11-06 2025-09-30 13F ABBVIE COM 00287Y109 4,858 1 0.02 1,125 24.75 0.1730
2025-08-07 2025-06-30 13F ABBVIE COM 00287Y109 4,857 29 0.60 902 -10.88 0.1469
2025-05-06 2025-03-31 13F ABBVIE COM 00287Y109 4,828 1 0.02 1,012 17.97 0.1751
2025-02-04 2024-12-31 13F ABBVIE COM 00287Y109 4,827 1 0.02 858 -9.98 0.1507
2024-11-06 2024-09-30 13F ABBVIE COM 00287Y109 4,826 1 0.02 953 15.11 0.1790
2024-08-05 2024-06-30 13F ABBVIE COM 00287Y109 4,825 -84 -1.71 828 -7.39 0.1713
2024-05-06 2024-03-31 13F ABBVIE COM 00287Y109 4,909 2 0.04 894 17.50 0.1918
2024-02-06 2023-12-31 13F ABBVIE COM 00287Y109 4,907 528 12.06 761 16.56 0.1819
2023-11-06 2023-09-30 13F ABBVIE COM 00287Y109 4,379 1 0.02 653 10.70 0.1772
2023-08-07 2023-06-30 13F ABBVIE COM 00287Y109 4,378 -51 -1.15 590 -16.45 0.1555
2023-05-12 2023-03-31 13F ABBVIE COM 00287Y109 4,429 102 2.36 706 0.86 0.1942
2023-02-13 2022-12-31 13F ABBVIE COM 00287Y109 4,327 2 0.05 699 20.31 0.2024
2022-11-07 2022-09-30 13F ABBVIE COM 00287Y109 4,325 1 0.02 581 -12.24 0.1878
2022-08-10 2022-06-30 13F ABBVIE COM 00287Y109 4,324 -135 -3.03 662 -8.44 0.2049
2022-05-09 2022-03-31 13F ABBVIE COM 00287Y109 4,459 259 6.17 723 27.07 0.2075
2022-02-11 2021-12-31 13F ABBVIE COM 00287Y109 4,200 337 8.72 569 36.45 0.1613
2021-11-08 2021-09-30 13F ABBVIE COM 00287Y109 3,863 -382 -9.00 417 -12.76 0.1307
2021-08-06 2021-06-30 13F ABBVIE COM 00287Y109 4,245 392 10.17 478 14.63 0.1502
2021-05-07 2021-03-31 13F ABBVIE COM 00287Y109 3,853 -490 -11.28 417 -10.32 0.1416
2021-02-09 2020-12-31 13F ABBVIE COM 00287Y109 4,343 509 13.28 465 38.39 0.1698
2020-11-06 2020-09-30 13F ABBVIE COM 00287Y109 3,834 609 18.88 336 5.99 0.1392
2020-08-07 2020-06-30 13F ABBVIE COM 00287Y109 3,225 3,225 317 0.1443
2020-05-08 2020-03-31 13F ABBVIE COM 00287Y109 0 -2,523 -100.00 0 -100.00
2020-02-07 2019-12-31 13F ABBVIE COM 00287Y109 2,523 2,523 223 0.0951
2019-05-07 2019-03-31 13F ABBVIE COM 00287Y109 0 -2,434 -100.00 0 -100.00
2019-02-07 2018-12-31 13F ABBVIE COM 00287Y109 2,434 13 0.54 224 -2.18 0.1268
2018-11-06 2018-09-30 13F ABBVIE COM 00287Y109 2,421 12 0.50 229 2.69 0.1061
2018-08-07 2018-06-30 13F ABBVIE COM 00287Y109 2,409 11 0.46 223 -1.76 0.1065
2018-05-07 2018-03-31 13F ABBVIE COM 00287Y109 2,398 7 0.29 227 -1.73 0.1085
2018-02-06 2017-12-31 13F ABBVIE COM 00287Y109 2,391 -149 -5.87 231 2.21 0.1107
2017-11-09 2017-09-30 13F ABBVIE COM 00287Y109 2,540 2,540 226 0.1133
2015-08-04 2015-06-30 13F ABBVIE COM 00287Y109 0 -3,988 -100.00 0 -100.00
2015-05-05 2015-03-31 13F ABBVIE COM 00287Y109 3,988 9 0.23 233 -10.38 0.1623
2015-02-06 2014-12-31 13F ABBVIE COM 00287Y109 3,979 7 0.18 260 13.54 0.1880
2014-11-05 2014-09-30 13F ABBVIE COM 00287Y109 3,972 -1,237 -23.75 229 -22.11 0.1751
2014-08-07 2014-06-30 13F ABBVIE COM 00287Y109 5,209 9 0.17 294 10.11 0.2262
2014-05-06 2014-03-31 13F ABBVIE COM 00287Y109 5,200 8 0.15 267 -2.55 0.2137
2014-02-05 2013-12-31 13F ABBVIE COM 00287Y109 5,192 -200 -3.71 274 13.69 0.2165
2013-11-06 2013-09-30 13F ABBVIE COM 00287Y109 5,392 200 3.85 241 12.09 0.2137
2013-08-09 2013-06-30 13F ABBVIE COM 00287Y109 5,192 5,192 215 0.2079
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.